DENTSPLY SIRONA Inc. (XRAY)
XRAY trades on Nasdaq in Health Care, Medical/Dental Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/818479/000081847926000075/0000818479-26-000075-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.
Profile
| Field | Value |
|---|---|
| Ticker | XRAY on Nasdaq |
| Sector | Health Care |
| Industry | Medical/Dental Instruments |
| Country | United States |
| IPO year | 1987 |
| SEC CIK | 0000818479 |
| SEC industry code | Dental Equipment & Supplies |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $3.7B |
| Net income | -$598.0M |
| Operating income | -$422.0M |
| Net margin | -16.3% |
| Operating margin | -11.5% |
| Revenue growth | -3.0% |
| Cash | $326.0M |
| Total assets | $5.4B |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 0.5× |
Warning signs
| Sign | Finding | Source |
|---|---|---|
| Going concern | No going-concern finding. | 10-Q 2026-11-05 |
| Cash and burn | $195.0M cash; operating cash flow $68.0M a quarter. | Report 2026-09-30 |
| Shares outstanding | 198,153,678 (2026-10-23); 199,551,969 a year earlier; 211,860,391 three years earlier. | Cover page 2026-10-23 |
| Reverse splits, 3 years | None found | None on EDGAR |
| Shelf and offerings, 12 months | 0 S-3/F-3 shelf filings; 0 424B5 takedowns | None on EDGAR |
| Exchange deficiency notices, 12 months | None | None on EDGAR |
| Auditor | Deloitte & Touche LLP, Charlotte, North Carolina, United States | PCAOB Form AP 2026-03-16 |
| Late filings, 12 months | None | None on EDGAR |
| Insider trades, 12 months | Bought $1.7M, sold $916K on the open market | SEC Forms 3/4/5 data sets 2026-09-30 |
From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.
Quarterly results
| Quarter | Revenue | Net income | Op. cash flow | Cash | Total debt | TTM revenue | Source |
|---|---|---|---|---|---|---|---|
| Q3 2026 2026-09-30 | $836.0M | -$2.0M | $32.0M | $195.0M | $2.2B | $3.6B | 10-Q 2026-11-05 |
| Q2 2026 2026-06-30 | $898.0M | $37.0M | $99.0M | $239.0M | $2.2B | $3.6B | 10-Q 2026-08-06 |
| Q1 2026 2026-03-31 | $880.0M | -$10.0M | $40.0M | $190.0M | $2.2B | $3.7B | 10-Q 2026-05-05 |
| Q4 2025 2025-12-31 | $961.0M | -$146.0M | $101.0M | $326.0M | $2.3B | $3.7B | 10-K 2026-02-26 |
| Q3 2025 2025-09-30 | $904.0M | -$427.0M | $79.0M | $363.0M | $2.4B | $3.6B | 10-Q 2026-11-05 |
| Q2 2025 2025-06-30 | $936.0M | -$45.0M | $48.0M | $359.0M | $2.4B | $3.7B | 10-Q 2026-08-06 |
| Q1 2025 2025-03-31 | $879.0M | $20.0M | $7.0M | $398.0M | $2.3B | $3.7B | 10-Q 2026-05-05 |
| Q4 2024 2024-12-31 | $905.0M | -$430.0M | $87.0M | $272.0M | $1.7B | $3.8B | 10-K 2026-02-26 |
From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B2 | 2025-06-09 |
| Latest annual report | 10-K | 2026-02-26 |
| Latest quarterly / interim | 10-Q | 2026-11-05 |
| Latest current report | 8-K | 2026-11-05 |
| Latest proxy | DEFA14A | 2026-04-23 |
Source: SEC EDGAR submissions feed, 1,004 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | -3.2% |
| 1 month | +7.6% |
| 3 months | -20.9% |
| Year to date | -19.9% |
| 1 year | -16.3% |
| From 52-week high | -37.6% |
Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Medical/Dental Instruments
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| LMAT | LeMaitre Vascular Inc. | $77.01 | -1.63% | $1.8B |
| INSP | Inspire Medical Systems Inc. | $59.12 | -3.24% | $1.7B |
| KMTS | Kestra Medical Technologies Ltd. | $27.97 | -2.34% | $1.7B |
| UFPT | UFP Technologies Inc. | $298.54 | -2.14% | $2.3B |
| PRCT | PROCEPT BioRobotics Corporation | $23.54 | -1.09% | $1.4B |
| NVCR | NovoCure Limited | $11.30 | -4.48% | $1.3B |
| TNDM | Tandem Diabetes Care Inc. | $18.48 | -7.92% | $1.3B |
| ATRC | AtriCure Inc. | $55.31 | -2.69% | $2.8B |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier